By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101


SEARCH JOBS


Industry
Biotechnology






Company News
BioLineRx Presents Positive Phase 2a AML Study And Mechanism-Of-Action Data For BL-8040 Oncology Platform At American Society of Hematology 2016 12/5/2016 10:59:38 AM
BioLineRx Reports Third Quarter 2016 Financial Results 11/22/2016 9:47:02 AM
BioLineRx In-Licenses Novel Anti-Inflammatory Treatment For Dry Eye Syndrome Under Strategic Collaboration With Major Global Pharmaceutical Company 11/21/2016 8:53:19 AM
BioLineRx To Report Third Quarter Results On November 22, 2016 11/15/2016 11:13:01 AM
BioLineRx Discloses Positive Correlative Data From Phase 2a AML Study And Mechanism-Of-Action Data For BL-8040 Oncology Platform At American Society of Hematology 2016 11/3/2016 8:38:20 AM
BioLineRx Announces Acceptance Of BL-8040 Abstracts For Oral And Poster Presentations At 58th American Society of Hematology Annual Meeting 10/5/2016 9:44:28 AM
BioLineRx Announces In-Licensing Of Novel Treatment For Liver Failure Conditions Under Strategic Collaboration 9/23/2016 10:54:24 AM
BioLineRx Presents Corporate Objectives At Investor Breakfast Meeting In NY 9/22/2016 10:47:41 AM
BioLineRx Announces Initiation Of Phase 2a Trial Of BL-8040 In Combination With KEYTRUDA (Pembrolizumab) For Treatment Of Pancreatic Cancer 9/20/2016 9:46:25 AM
BioLineRx To Host Investor Breakfast Meeting September 22, 2016 In New York 9/12/2016 11:24:27 AM
12345678910...
//-->